fda approval tirzepatide for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly FDA approval for Zepbound: FSU

Ferrostatin-1 mitigates ionizing radiation-induced intestinal injuries by inhibiting apoptosis and ferroptosis: an in vitro and in vivo study

Private insurance plans in the United States and employer-sponsored health benefits increasingly include GLP-1 medications in formularies, though often with prior authorization requirements and step therapy protocols

With growing awareness of GLP-1 medications like Ozempic and Wegovy, many people are exploring complementary solutions or alternatives that offer similar benefitswithout the need for injections or prescriptions

This information and product advice is not intended as advice or recommendations for any specific use or circumstance

"At this point, I've lost the plot